Regions Financial Corp Moderna, Inc. Transaction History

Regions Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$126.46 - $235.05 $118,493 - $220,241	-937 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$225.82 - $368.51 $59,390 - $96,918	263 Added 39.02%	937 $238,000
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $149,560 - $326,532	674 New	674 $259,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.